Grace Halsey

September 21, 2021

COVID-19 case increases in the past 7 days range from 100% to 3.16% among the 10 states with the most significant rises. Is your state among these?

September 21, 2021

Strong evidence from a large, real-world evidence study, and preliminary data from a phase 3 booster-dose trial may support J&J's next steps toward FDA authorization of a COVID-19 booster.

September 20, 2021

Pfizer/BioNTech report "robust" antibody response to COVID-19 vaccine in children aged 5 to 11 years with safety profile comparable to that seen in persons aged 16 to 25 years.

September 20, 2021

CCTA identified atherosclerosis in >40% of middle-aged adults without known coronary heart disease, report Swedish investigators; significant stenosis was found in another 5.2%.

September 17, 2021

Dapagliflozin adds substantial improvements in symptoms, exercise function to demonstrated disease-modifying properties for patients with HFpEF.

September 16, 2021

Avoidable COVID-19 hospitalizations for unvaccinated persons in the US have cost an estimated $5 billion since June, according to a new study.

September 15, 2021

Identifying white coat and masked hypertension is essential for prevention of CV morbidity and mortality. Review the ACC/AHA recommendations on how to detect and manage.

September 15, 2021

Each doubling of levels of 4 stress hormones was associated with a 21-31% increase in risk of developing hypertension over a median 6.5-year follow-up.

September 14, 2021

According to the CDC, Vermont right now has the highest and Wyoming the lowest percentage of its state's population fully vaccinated against COVID-19.

September 14, 2021

The DHE nasal spray delivered pain relief at 2 hours for 66% of patients; 93% of those remained pain-free at 24 hours and 86% at 2 days post-dose.